Browse > Article
http://dx.doi.org/10.9718/JBER.2017.38.5.271

A Panel of Serum Biomarkers for Diagnosis of Prostate Cancer  

Cho, Jung Ki (Department of Convergence Technology, Graduate School of Venture, Hoseo University)
Kim, Younghee (Department of Convergence Technology, Graduate School of Venture, Hoseo University)
Publication Information
Journal of Biomedical Engineering Research / v.38, no.5, 2017 , pp. 271-276 More about this Journal
Abstract
Cancer biomarkers are using in the diagnosis, staging, prognosis and prediction of disease progression. But, there are not sufficiently profiled and validated in early detection and risk classification of prostate cancer. In this study, we have devoted to finding a panel of serum biomarkers that are able to detect the diagnosis of prostate cancer. The serum samples were consisted of 111 prostate cancer and 343 control samples and examined. Eleven biomarkers were constructed in this study, and then nine biomarkers were relevant to candidate biomarkers by using t test. Finally, four biomarkers, PSA, ApoA2, CYFRA21.1 and TTR, were selected as the prostate cancer biomarker panel, logistic regression was used to identify algorithms for diagnostic biomarker combinations(AUC = 0.9697). A panel of combination biomarkers is less invasive and could supplement clinical diagnostic accuracy.
Keywords
Serum biomarker; Prostate cancer; algorithm;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Schroder FH1, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Maattanen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ and Auvinen A. "Screening and prostate-cancer mortality in a randomized European study", The New England Journal of Medicine, vol. 360, no. 13, pp. 1320-1328, 2009.   DOI
2 R Development Core Team, "A Language and Environment for Statistical Computing. Vienna, Austria : the R Foundation for Statistical Computing", ISBN 3-900051-07-0, [http://www.R-project.org], 2007.
3 Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. "Global cancer statistics", Ca-A Cancer Journal For Clinicians, vol. 61, no. 2, pp. 69-90, 2011.   DOI
4 Boyle P and Ferlay J. "Cancer incidence and mortality in Europe, 2004", Annals of Oncology, vol. 16, no. 3, pp. 481-488, 2005.   DOI
5 Quinn M and Babb P. "Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons", BJU International, vol. 90, no. 2, pp. 174-184, 2002.   DOI
6 Parkin DM, Bray FI and Devesa SS. "Cancer burden in the year 2000. The global picture", European Journal of Cancer, vol. 37, no. 8, pp. 4-66, 2001.
7 Jaeryun Lee, "The Clinical Lecture _ Guidelines of Cancer Care for general practitioner : Prostate Cancer", Korean Journal of Internal Medicine Autumn, vol. 2013, no. 2, pp. 116-120, 2013.
8 Smith DS and Catalona WJ. "Interexaminer variability of digital rectal examination in detecting prostate cancer", Urology, vol. 45, no. 1, pp. 70-74, 1995.   DOI
9 Chodak GW, Keller P and Schoenberg HW. "Assessment of screening for prostate cancer using the digital rectal examination", Journal of Urology, vol. 41, no. 5, pp. 1136-1138, 1989.
10 Cooperberg MR, Broering JM, Kantoff PW and Carroll PR. "Contemporary trends in low risk prostate cancer: risk assessment and treatment", Journal of Urology, vol. 178, no. 3, pp. 14-19, 2007.   DOI